LMR Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History

LMR Partners’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,792	Closed	-$440K	–	1513
2021 Q1	$440K	Buy	+10,792	New	+$496K	0.01%	668
2020 Q4	–	Sell	-21,693	Closed	-$1.2M	–	672
2020 Q3	$1.2M	Sell	21,693 -3,828	-15%	-$243K	0.02%	192
2020 Q2	$1.61M	Buy	+25,521	New	+$1.75M	0.04%	291
2016 Q3	–	Sell	-63,531	Closed	-$1.05M	–	522
2016 Q2	$1.05M	Buy	+63,531	New	+$1.28M	0.16%	180

Other funds holding GBT

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

LMR Partners's GBT Position: Q2 2021 in Review

LMR Partners sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2021, closing a stake of 10,792 shares — an estimated $440K sold.

LMR Partners first reported a position in GBT in Q2 2016 and held it in 4 quarters. The position peaked at $1.61M in Q2 2020. 191 funds tracked by Wall St. Rank hold GBT as of Q2 2021.

LMR Partners reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
LMR Partners sold 10,792 Global Blood Therapeutics, Inc. shares in Q2 2021, an estimated $440K.
LMR Partners first reported a position in Global Blood Therapeutics, Inc. in Q2 2016 and held it in 4 quarters.
LMR Partners's Global Blood Therapeutics, Inc. position peaked at $1.61M in Q2 2020.
191 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2021.

Based on LMR Partners's 13F filing for Q2 2021, filed 16 Aug 2021.